Patents by Inventor So Yoon

So Yoon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250127459
    Abstract: An apparatus and method for diagnosing developmental disorder using an artificial neural network are disclosed. An apparatus for diagnosing developmental disorders according to one exemplary embodiment includes a communication unit that performs communication with one or more user terminals and a control unit connected to the communication unit, in which the control unit receives at least one of image data and voice data for an analysis target from the user terminal and performs a first developmental disorder diagnosis through one or more artificial neural networks learned to perform a developmental disorder diagnosis, receives questionnaire response data from the user terminal and performs a second developmental disorder diagnosis according to predetermined standard, and generates developmental disorder diagnosis data for the analysis target based on the first developmental disorder diagnosis and the second developmental disorder diagnosis.
    Type: Application
    Filed: October 22, 2024
    Publication date: April 24, 2025
    Inventors: Jae Hyun LIM, So Yoon JUNG
  • Publication number: 20250120643
    Abstract: Some aspects of the present disclosure are related to articles for measuring electrical signals internal to a subject, e.g., of the gastrointestinal tract (GI tract). The articles, in some embodiments, are ingestible and/or implantable. In some embodiments, the articles comprise a substrate comprising a plurality of electrodes, the substrate having a Young's elastic modulus of greater than or equal to 0.01 MPa and less than or equal to 200 MPa. In some such cases, the Young's elastic modulus of the substrate facilitates elastic recoil of the substrate such that at least a portion of the plurality of electrodes contact a surface of a tissue at the location internal to the subject (e.g., the GI tract) and thus facilitate measurement of electrical signals at the location internal to the subject. Other aspects are related to methods of using the articles, for example, to monitor electrical signals from the location internal to the subject.
    Type: Application
    Filed: October 11, 2024
    Publication date: April 17, 2025
    Applicants: Massachusetts Institute of Technology, The Brigham and Women's Hospital, Inc.
    Inventors: Robert S. Langer, Carlo Giovanni Traverso, Siheng You, So-Yoon Yang, Adam Gierlach, George Selsing
  • Patent number: 12268728
    Abstract: Provided are a recombinant hyaluronan and proteoglycan link protein 1 (HAPLN1), and a composition for preventing or treating pulmonary diseases, the composition comprising at least one selected from the group consisting of HAPLN1 (hyaluronan and proteoglycan link protein 1) protein, a gene coding for the HAPLN1 protein, and an effective agent for promoting the expression or activating the functions of HAPLN1 protein or gene as an active ingredient. The recombinant HAPLN1 according to the present disclosure may have superior effects of improving alveolar damage caused by aging or elastin reduction, and thus may effectively prevent or treat pulmonary diseases, such as chronic bronchitis, asthma, emphysema, and chronic obstructive pulmonary disease.
    Type: Grant
    Filed: February 2, 2021
    Date of Patent: April 8, 2025
    Assignee: HAPLNSCIENCE, INC.
    Inventors: Dae Kyong Kim, Yong Wei Piao, Ji Min Jang, Dan Zhou, So Yoon Yun, Bo Kyung Park
  • Publication number: 20250094088
    Abstract: A data processing system is provided to include a storage unit and a controller in communication with the storage unit and configured to program write data to a first area as at least one of the plurality of storage areas with a priority over a second area as at least one of the plurality of storage areas and transfer data of the first area to the second area. The controller is further configured to adjust a size of the first area based on 1) a number of times saturated by the write data for the first area, a saturation occurring due to a size of the write data written to the first area being greater than a certain size and 2) an overflow size of the write data corresponding to a difference between the size of the write data and the certain size.
    Type: Application
    Filed: November 26, 2024
    Publication date: March 20, 2025
    Inventors: Hyun Tae KIM, So Yoon JUNG
  • Patent number: 12239695
    Abstract: The present disclosure relates to a pharmaceutical composition comprising an exosome derived from a thrombin-treated stem cell as an effective ingredient for preventing or treating a skin wound, a pharmaceutical formulation containing the same, and a production method thereof. Being a cell-free agent, an exosome-based therapeutic agent of the present disclosure has a low risk of carcinogenesis and no problems of graft rejection as well as being little liable to occur microvascular obstruction. The agent, which is not a cell, but a material isolated from a cell, can be subjected to medication development into an off-the-shelf product which allows for the reduction of production cost. The agent has the advantage of exhibiting outstanding angiogenesis and skin wound treatment effects even at a low concentration of exosomes thanks to the thrombin treatment effect.
    Type: Grant
    Filed: June 27, 2017
    Date of Patent: March 4, 2025
    Assignee: SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
    Inventors: Yun Sil Chang, Won Soon Park, Dong Kyung Sung, So Yoon Ahn
  • Publication number: 20250064318
    Abstract: A device is configured to be administered via an oral route by a subject. The device includes an anode, a seal disposed on the anode, and a cathode. When exposed to a liquid or a hydrogel, an exposed surface of the anode undergoes galvanic oxidation dissolution to provide DC power to the device. As the exposed surface of the anode undergoes galvanic oxidation dissolution, the seal incrementally detaches from the anode, and a substantially constant surface area of the exposed surface is maintained.
    Type: Application
    Filed: December 28, 2022
    Publication date: February 27, 2025
    Applicant: Massachusetts Institute of Technology
    Inventors: Carlo Giovanni TRAVERSO, Jason Siu Wei Li, So-Yoon Yang
  • Patent number: 12198747
    Abstract: A memory includes: a plurality of word lines; and a row circuit configured to: activate at least one word line among the word lines to an active voltage level during an active operation and discharge the activated word line during a precharge operation; and discharge the word line from the active voltage level to a precharge voltage level in different manners during the precharge operation in response to a precharge command and during the precharge operation during a refresh operation.
    Type: Grant
    Filed: February 2, 2023
    Date of Patent: January 14, 2025
    Assignee: SK hynix Inc.
    Inventors: Sang Hyun Ku, Do Hong Kim, Min Ho Seok, Duck Hwa Hong, So Yoon Kim
  • Patent number: 12169645
    Abstract: A data processing system is provided to include a storage unit and a controller in communication with the storage unit and configured to program write data to a first area as at least one of the plurality of storage areas with a priority over a second area as at least one of the plurality of storage areas and transfer data of the first area to the second area. The controller is further configured to adjust a size of the first area based on 1) a number of times saturated by the write data for the first area, a saturation occurring due to a size of the write data written to the first area being greater than a certain size and 2) an overflow size of the write data corresponding to a difference between the size of the write data and the certain size.
    Type: Grant
    Filed: November 9, 2021
    Date of Patent: December 17, 2024
    Assignee: SK HYNIX INC.
    Inventors: Hyun Tae Kim, So Yoon Jung
  • Publication number: 20240312503
    Abstract: A memory device includes a plurality of word lines; and a row control circuit configured to: drive, in response to a precharge command, a selected word line of the word lines such that a voltage level of the selected word line decreases from a first voltage level to a second voltage level during a first section, stays at the second voltage level during a second section and decreases from the second voltage level to a third voltage level during a third section, and keep the second section at a preset time amount, or change the second section to a time amount defined by an input of an active command according to a mode control signal.
    Type: Application
    Filed: July 25, 2023
    Publication date: September 19, 2024
    Inventors: Sang Hyun KU, Do Hong KIM, Duck Hwa HONG, Min Ho SEOK, So Yoon KIM
  • Publication number: 20240161806
    Abstract: A memory includes: a plurality of word lines; and a row circuit configured to: activate at least one word line among the word lines to an active voltage level during an active operation and discharge the activated word line during a precharge operation; and discharge the word line from the active voltage level to a precharge voltage level in different manners during the precharge operation in response to a precharge command and during the precharge operation during a refresh operation.
    Type: Application
    Filed: February 2, 2023
    Publication date: May 16, 2024
    Inventors: Sang Hyun KU, Do Hong Kim, Min Ho Seok, Duck Hwa Hong, So Yoon Kim
  • Publication number: 20230405050
    Abstract: The present invention relates to: a pharmaceutical composition for preventing or treating infectious diseases, comprising, as an active ingredient, exosomes derived from thrombin-treated stem cells; a pharmaceutical formulation containing same; and a preparation method therefor. The present inventors specifically have identified that exosomes isolated from thrombin-treated stem cells significantly reduce the expression of inflammatory cytokines under inflammatory conditions, and thus it is expected that the exosomes derived from thrombin-treated stem cells, according to the present invention, can be effectively used in related fields for the purpose of alleviating or treating various infectious diseases caused by immune responses or inflammatory responses induced through infection.
    Type: Application
    Filed: November 23, 2021
    Publication date: December 21, 2023
    Inventors: Yun Sil CHANG, Won Soon PARK, So Yoon AHN, Dong Kyung SUNG
  • Patent number: 11833176
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating neonatal hypoxic ischemic encephalopathy (HIE), comprising thrombin-treated stem cells or exosomes derived therefrom as an active ingredient, and a method for producing the same. According to the present invention, the thrombin-treated stem cell or the exosome derived therefrom has an increased expression of growth factors, immunoregulatory factors, antioxidation factors, or regeneration factors compared to a group not treated with thrombin and also enhances a neuronal apoptosis inhibitory effect, and thus has an advantage in that the therapeutic effect thereof on neonatal hypoxic ischemic encephalopathy (HIE) is excellent.
    Type: Grant
    Filed: October 31, 2017
    Date of Patent: December 5, 2023
    Assignee: MEDINNO INC.
    Inventors: Yun Sil Chang, Won Soon Park, So Yoon Ahn, Dong Kyung Sung
  • Patent number: 11826441
    Abstract: Provided is a cleansing foam cosmetic composition comprising amino acid-based surfactants, and more particularly to a cleansing foam cosmetic composition in which a nonionic or amphiprotic surfactant is not used, and which comprises amino acid-based surfactants consisting of only sodium lauroyl glutamate, sodium cocoyl glycinate, and potassium cocoyl glycinate.
    Type: Grant
    Filed: June 23, 2022
    Date of Patent: November 28, 2023
    Assignees: KOLMAR KOREA CO., LTD., SHINSEGAE INTERNATIONAL INC.
    Inventors: Yan Sun, Min Kyung Kim, Young Seok Kim, Yi Soo Bae, Jun Oh Kim, Sang Keun Han, So Yoon Baek, Kang Tae Lee, So Hyeon Mok
  • Patent number: 11648819
    Abstract: An indoor heating line is arranged to pass through a heater core for a coolant heater and indoor air conditioning, and is provided with a first pump so that coolant can flow. A battery heating line is branched from a downstream point of the heater core and connected to an upstream point of the coolant heater after passing through a battery heat exchange part for temperature-raising a high voltage battery, where the battery heating line includes a first heat exchange flow passage that connects a downstream point of the heater core to a first side of the battery heat exchange part, and a second heat exchange flow passage that connects a second side thereof and an upstream point of the coolant heater, where the first heat exchange flow passage and the second heat exchange flow passage are configured to mutually exchange heat.
    Type: Grant
    Filed: November 10, 2021
    Date of Patent: May 16, 2023
    Assignees: Hyundai Motor Company, Kia Corporation
    Inventors: Sang Shin Lee, Man Ju Oh, So Yoon Park, Jae Woong Kim
  • Patent number: 11634009
    Abstract: An indoor heating line is arranged to pass through a heater core for a coolant heater and indoor air conditioning, and is provided with a first pump so that coolant can flow. A battery heating line is branched from a downstream point of the heater core and connected to an upstream point of the coolant heater after passing through a battery heat exchange part for temperature-raising a high voltage battery, where the battery heating line includes a first heat exchange flow passage that connects a downstream point of the heater core to a first side of the battery heat exchange part, and a second heat exchange flow passage that connects a second side thereof and an upstream point of the coolant heater, where the first heat exchange flow passage and the second heat exchange flow passage are configured to mutually exchange heat.
    Type: Grant
    Filed: November 11, 2021
    Date of Patent: April 25, 2023
    Assignees: Hyundai Motor Company, Kia Corporation
    Inventors: Sang Shin Lee, Man Ju Oh, So Yoon Park, Jae Woong Kim
  • Patent number: 11634008
    Abstract: An indoor heating line is arranged to pass through a heater core for a coolant heater and indoor air conditioning, and is provided with a first pump so that coolant can flow. A battery heating line is branched from a downstream point of the heater core and connected to an upstream point of the coolant heater after passing through a battery heat exchange part for temperature-raising a high voltage battery, where the battery heating line includes a first heat exchange flow passage that connects a downstream point of the heater core to a first side of the battery heat exchange part, and a second heat exchange flow passage that connects a second side thereof and an upstream point of the coolant heater, where the first heat exchange flow passage and the second heat exchange flow passage are configured to mutually exchange heat.
    Type: Grant
    Filed: November 9, 2021
    Date of Patent: April 25, 2023
    Assignees: Hyundai Motor Company, Kia Corporation
    Inventors: Sang Shin Lee, Man Ju Oh, So Yoon Park, Jae Woong Kim
  • Publication number: 20230000732
    Abstract: Provided is a cleansing foam cosmetic composition comprising amino acid-based surfactants, and more particularly to a cleansing foam cosmetic composition in which a nonionic or amphiprotic surfactant is not used, and which comprises amino acid-based surfactants consisting of only sodium lauroyl glutamate, sodium cocoyl glycinate, and potassium cocoyl glycinate.
    Type: Application
    Filed: June 23, 2022
    Publication date: January 5, 2023
    Inventors: YAN SUN, MIN KYUNG KIM, YOUNG SEOK KIM, YI SOO BAE, JUN OH KIM, SANG KEUN HAN, SO YOON BAEK, KANG TAE LEE, SO HYEON MOK
  • Publication number: 20230003714
    Abstract: The present invention relates to use of PAK4 and CRTC1 or the treatment or diagnosis of a degenerative brain disease. Specifically, the present invention relates to a pharmaceutical composition for the prevention or treatment of a degenerative brain disease comprising PAK4 (p21-activated kinase 4) or a PAK4 activator as an effective ingredient.
    Type: Application
    Filed: August 22, 2022
    Publication date: January 5, 2023
    Inventors: Eung Gook KIM, So Yoon WON, Eun Young SHIN
  • Publication number: 20220374172
    Abstract: A data processing system is provided to include a storage unit and a controller in communication with the storage unit and configured to program write data to a first area as at least one of the plurality of storage areas with a priority over a second area as at least one of the plurality of storage areas and transfer data of the first area to the second area. The controller is further configured to adjust a size of the first area based on 1) a number of times saturated by the write data for the first area, a saturation occurring due to a size of the write data written to the first area being greater than a certain size and 2) an overflow size of the write data corresponding to a difference between the size of the write data and the certain size.
    Type: Application
    Filed: November 9, 2021
    Publication date: November 24, 2022
    Inventors: Hyun Tae KIM, So Yoon JUNG
  • Patent number: 11476400
    Abstract: A ventilation module can be used with a ventilation seat for a vehicle. A thermoelectric air-conditioning part has a thermoelectric unit performing heat absorption and heat generation by using a Peltier effect when electric power is applied, a cooling unit provided at a first side of the thermoelectric unit, and a heat dissipation unit provided at a second side of the thermoelectric unit. The module is configured so that air that is supplied from a blower is cooled by the thermoelectric air-conditioning part, passes through a cooling fin of the cooling unit, and is discharged to an interior of the vehicle through a seat cushion. The module is configured so that air that is supplied from the blower is heated by the thermoelectric air-conditioning part, passes through a heat dissipating fin of the heat dissipation unit, and is discharged through the heat dissipation path.
    Type: Grant
    Filed: April 16, 2019
    Date of Patent: October 18, 2022
    Assignees: Hyundai Motor Company, Kia Motors Corporation
    Inventors: Man Ju Oh, Sang Shin Lee, Jae Woo Park, So Yoon Park, Jae Woong Kim, So La Chung